TANG CAPITAL MANAGEMENT LLC
Q1 2014 13F-HR Holdings
Net value change ($000)
+63,213
(44.2%)
New positions
4
Sold out positions
3
Turnover %
59.3%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q4 2013
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| HRTX | 61,329 | NEW |
| Horizon Therapeutics PLC Com | 15,120 | NEW |
| ENDOCYTE INC | 6,116 | 123.0% |
| SALIX PHARMACEUTICAL | 4,101 | 15.2% |
| MANNKIND CORP | 1,670 | 30.0% |
| LA JOLLA PHARMACEUTICAL CO | 121 | NEW |
| RXI PHARMACEUTICALS CORP NEW | 78 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| ONCOGENEX PHARMACEUTICALS IN | -8,616 | -100.0% |
| Mirati Therapeutics, Inc. | -7,296 | -46.7% |
| SOPHIRIS BIO INC. | -1,850 | -100.0% |
| BMRN | -390 | -3.0% |
| OPK | -94 | -100.0% |
| DENDREON CORP COM | -72 | -30.3% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|